Ray Therapeutics, Inc. announced that it has received $125 million in funding from a group of investors

Published: 2026-04-21 12:06:17 ET BEN

Published on 04/21/2026 at 12:06 pm EDT

Ray Therapeutics, Inc. announced that it has received $125 million in a round of funding led by new investor Janus Henderson Investors US LLC on April 21, 2026. The transaction included participation from returning investors 4BIO Partners LLP, Novo Holdings A/S, Deerfield Capital, L.P., Norwest Venture Capital Management, Inc., Platanus Ventures, MRL Ventures Fund LLC, new investors Adage Capital Management, L.P., Franklin Resources, Inc., The Invus Group, LLC, and Marshall Wace LLP. The company issued convertible preferred shares in the transaction.